Canada is set to be the first country to give citizens the option for a vegetarian coronavirus shot. The world’s first plant-derived Covid vaccine, Covifenz, was cleared for use in
Vaccines
Public health authorities and vaccine makers have debated whether an omicron-specific booster or additional shots will be necessary to protect those already immunized as the COVID-19 pandemic continues. While data
The company as been awarded the contract by the US Biomedical Advanced Research and Development Authority (BARDA). Rapid Micro Biosystems, a provider of automated, non-destructive, rapid microbial detection, has received
Eli Lilly has signed up CureVac to develop cancer vaccines based on its mRNA technology, in a deal that could potentially be worth more than $2.6 billion to the German
SGS announced it has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specialising in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain. This will
The BBC has reported that researchers from the University of Oxford’s Jenner Institute are seeking 500 NHS patients to test a new ‘universal’ vaccine for seasonal influenza, which may give
Pfizer has secured approval the European Commission (EC) for TRUMENBA (Meningococcal Group B Vaccine) for preventing invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years
Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus.
This growth is across the nine major countries of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil and China The human immunodeficiency virus (HIV) market is set to
Targovax has recruited its first patient in a Phase Ib trial for its new cancer vaccine TG02 targeting mutations of the RAS gene. Mutations of the RAS gene disrupt normal cell
Italy adopts gender-neutral HPV vaccination program, citing study by health economics expert from Kingston University London’s Business School. The Italian government has changed its policy to allow both boys and
Biotech company Nemaura Pharma has secured up to £5 million funding from private investors for the development of a hormone biologic using its Micro-Patch solid dose delivery platform. The company’s
Advertisements
